Aristotle University Of Thessaloniki (AUTH)
Επίδραση δύο στατινών στην 24ωρη διακύμανση της αρτηριακής σκληρίας και της κεντρικής αορτικής πίεσης σε ασθενείς με δυσλιπιδαιμία
Abstract
dc:descriptionObjective: Arterial stiffness is an independent cardiovascular risk factor. Statins beyond their hypolipidemic effects, exhibit multiple beneficial pleiotropic effects on the cardiovascular system and there is evidence that they could also improve arterial stiffness directly. The purpose of this study was to evaluate the effect of statins on the 24 hour fluctuation of arterial stiffness and central aortic pressure in patients with isolated dyslipidaemia without associated cardiovascular disease, who did not receive any additional treatment.Methods: Fifty-two patients were randomized to receive either a potent (rosuvastatin 10 mg) or a mild statin (simvastatin 20 mg) over 6 months to achieve the LDL-C target <115 mg/dl, and were assessed before and after treatment for arterial hardness parameters: central aortic pressure (cBP), central augmentation index (A1x) and pulse wave velocity (PWV). If a patient, regardless of group, could not achieve the LDL-C target at the end of the first follow-up month, was excluded from the study. Of the 52 patients, 44 patients, 22 in each group, achieved the LDL-C target at the end of the first month and continued the study.24-hour arterial hardness was evaluated with the Mobil-O-Graph 24h PWA Monitor. At the same time, correlation of the arterial sclerosis parameters of the screening of both groups was performed in relation to the two methods used (24-hour recording with Mobil-O-Graph 24h PWA Monitor and the Sphygmocor device) with Spearman's rho correlation coefficient .Results: The two groups were similar in age, gender, smoking, BMI, but also in most other measurements. However, there was a difference in LDL-C levels (with p <0.015) and central systolic blood pressure (with p <0.020) at the start of the study, which in the case of LDL-C was eliminated at 6 months, and in the case of central systolic pressure it remained stable. Dispite all patients achiving the LDL-C target, no statistically significant differentiation was observed in several of the parameters of arterial stiffness (PWV, Aix75, central systolic / diastolic pressure) in either group.As expected, the reduction in total cholesterol and LDL-C was particularly evident in both groups. To a lesser degree, in both groups, triglyceride levels decreased and values of HDL-C were also increased at statistically significant levels. In addition, in the rosuvastatin group there was also a decrease in uric acid which was absent in the simvastatin group. It is noteworthy that the sphygmocor and mobilograph methods showed statistically significant differences in baseline measurements of arterial stiffness at initiation of treatment at the screening visit.It is noteworthy that the two methods, Mobil-O-Graph 24h PWA Monitor and Sphygmocor, showed strong correlation in both groups (p <0.001) to the baseline measurements for arterial stiffness performed at the screening visit: PWV, marker (Aix75), central systolic, diastolic pressure and pulse pressure (cPP, cSBP and cDBP). However, the correlation was weak since for all parameters of the hardness the correlation coefficients were low (R2 Linear <0.5).Conclusions: In patients with low cardiovascular risk with physiological parameters of arterial stiffness, administration of statins does not reduce arterial stiffness, thus it should be based on their hypolipidemic action and not their pleiotropic characteristics which, of course, should be taken into account at a personalized level.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2019
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Reklou, Andromachi
- Ρέκλου, Ανδρομάχη
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/45927